logo
Electronic Caregiver Launches Addison Care: The First Avatar-Driven Virtual Health Assistant Serving Medicare Patients Under CMS Reimbursement

Electronic Caregiver Launches Addison Care: The First Avatar-Driven Virtual Health Assistant Serving Medicare Patients Under CMS Reimbursement

Las Cruces, New Mexico--(Newsfile Corp. - June 30, 2025) - Electronic Caregiver Inc., a national leader in AI-powered digital health solutions, proudly announces the launch of Addison Care, the industry's first 3D, avatar-based virtual caregiver now shipping to and serving Medicare patients under CMS reimbursement codes for Remote Patient Monitoring (RPM) and Chronic Care Management (CCM).
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/9474/257008_697053e234f58b94_002.jpg ]
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9474/257008_697053e234f58b94_002full.jpg
Addison Care has officially launched with the first four clinical locations, with new rollouts scheduled in additional regions. Capstone Clinic, one of the largest primary care physician groups in Alaska, is the first clinic to utilize Addison Care for RPM and CCM services. These telehealth services are critically important to patients living in rural Alaska where access to emergency care can be hours away. Despite this urgent need, past programs were unsuccessful due to limited patient engagement and no EHR integration. Addison Care addresses both issues.
'Direct integration of ECG's Addison Care product into the athenaOne EHR used by Capstone Clinic is a game changer,' says Jason Haugen, CEO of Pinnacle Integrated Medicine, Electronic Caregiver's EHR integration partner. 'The resulting workflow, alerting, and claims reporting automations enable clinics to 10x their RPM and CCM programs with no increase in staffing or administrative expenses. The impact on operational efficiencies, patient care, and ROI are unmatched.'
Fulfilling Dr. Oz's vision for an AI-powered health avatar
The long-awaited 3D experience represents a major leap forward in home-centered care to achieve patient engagement, provide companionship, and drive health outcomes. Addison Care is built on the Addison engine, which has already delivered vital services, including remote monitoring, medication reminders, and AI-powered health surveys, to tens of thousands of patients nationwide via Electronic Caregiver's interactive smart health hubs.
'This isn't a software tool—it's a real-life companion, built from the ground up to support the aging, ill, and disabled with compassion and precision,' said Anthony Dohrmann, CEO of Electronic Caregiver. 'Addison is the only interface of its kind offered under existing reimbursement codes by CMS and built for true daily interaction with patients at home. This isn't just a product launch. It's a paradigm shift,' said Dohrmann. 'While the industry builds low-use apps for mobile and EHRs, we built Addison Care for the real world, to serve the aging, ill, and disabled where care is needed most: daily in the home.'
A New Standard in 'Ever-Present' Virtual Care
Addison Care isn't just a health tech product; it's a transformative, personalized, 24/7 health assistant designed to support patients from age 5 to 105. Addison goes beyond vitals tracking to offer:
Addison's intuitive interface is simple enough that both young children and tech-averse seniors can engage with it naturally. Instead of navigating complex app interfaces, patients interact with a relatable, lifelike caregiver, offering support, encouragement, and critical intervention when needed.
Built for the Home, Integrated for the System
Addison Care is now becoming the exclusive patient interface for participating clinics. Backed by over 100 clinical organizations using Electronic Caregiver's broader RPM and CCM services, Addison already demonstrates increased patient engagement and measurable treatment adherence improvements.
The platform is fully integrated with athenahealth EHRs and powered by Electronic Caregiver's full-service TeleCare division, delivering human-supported, high-touch interventions at scale.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/9474/257008_697053e234f58b94_003.jpg ]
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9474/257008_697053e234f58b94_003full.jpg
AI That Heals, Not Just Tracks
Addison Care incorporates LLMs (large language models), intelligent behavioral analysis, and real-time orchestration to deliver precision, personalized care. The platform supports:
Addison is also the subject of a study conducted with UMASS, the National Institute on Aging, and the National Institutes of Health, focused on fall prediction and prevention in older adults-further validating its real-world impact.
Built for a Future in Crisis
With a projected 33% loss of physicians and nurses by 2030, Addison Care is designed to fill a critical void in the global healthcare system. Electronic Caregiver holds 28 awarded patents, including four in the past 60 days, with intellectual property and AI assets estimated to be valued at over $1.2 billion. Combined with real-world patient outcomes, the company is positioning Addison as a foundational home health solution in the coming decade.
Addison is now live in New Mexico, Alaska, and additional rural or high-barrier regions, with Colorado and Arkansas rollouts scheduled next.
'Most health tech is built around legacy systems and billing logic,' added Dohrmann. 'We built Addison around the patient, what they see, hear, feel, and need. We didn't guess. We spent years studying it in homes, labs, clinics, and hospitals. Now, the results are in their hands.'
About Electronic Caregiver, Inc.
Founded in 2009, Electronic Caregiver is a health technology company dedicated to advancing care through innovation. With over $50 million in revenue, more than 100 clinical partners, and a track record of market-defining technology, ECG has appeared twice on the Inc. 5000 list and remains at the forefront of remote care, emergency response, and virtual caregiving.
Contact Information
Travis Luevano
Director, Digital Marketing
[email protected]
(575) 649-7808
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257008
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

T-NeuroDx to Present Advances in Blood Test for Early Alzheimer's Detection at Major Conference
T-NeuroDx to Present Advances in Blood Test for Early Alzheimer's Detection at Major Conference

Associated Press

time7 hours ago

  • Associated Press

T-NeuroDx to Present Advances in Blood Test for Early Alzheimer's Detection at Major Conference

'We believe that studying the body's adaptive immune system will play a pivotal role in the early detection of Alzheimer's'— Dr. Wheeler ALBUQUERQUE, NM, UNITED STATES, July 27, 2025 / / -- T-NeuroDx, a company pioneering new diagnostic tools that use abnormalities in the immune system to detect Alzheimer's Disease, will present its latest research at the 2025 Alzheimer's Association International Conference (AAIC) in Toronto, Canada, from July 27–31. Dr. Christopher Wheeler, the company's Chief Science Officer, will share new findings about the company's promising blood test for Alzheimer's. The research focuses on identifying specific aged immune cells in the blood that act as an early warning sign, or 'biomarker,' for the disease. A significant breakthrough in this new study is the enhancement of the test to be effective for all Alzheimer's patients, a critical step toward making this technology widely available. This builds upon Dr. Wheeler's initial discovery of the biomarker announced last year . 'We believe that studying the body's adaptive immune system will play a pivotal role in the early detection of Alzheimer's,' said Dr. Wheeler. 'Our results strengthen our case for a scalable, blood-based diagnostic that can move us closer to timely intervention and improved outcomes.' T-NeuroDx's vision is to create simple, accessible blood tests that can help doctors diagnose Alzheimer's sooner, allowing for earlier treatment and better patient care. Presentation Details: • Poster Title: #107315 - Levels of age-related blood CD8 T cells binding a non-self peptide/HLA epitope track with Alzheimer's disease status in HLA-A2+ and HLA-A2- cohorts: a T cell biomarker assay applicable to all patients. • Session: Biomarkers (non-neuroimaging) track. • Event: Alzheimer's Association International Conference (AAIC) 2025 • Date: Monday, July 28, 2025 • Time: 7:30 AM – 4:15 PM EDT • Location: Toronto, Canada For more information about T-NeuroDx, please visit John Chavez T-NeuroDx +1 505-660-1046 [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

How nanoplastics may be impacting our long-term health
How nanoplastics may be impacting our long-term health

Yahoo

time19 hours ago

  • Yahoo

How nanoplastics may be impacting our long-term health

Albuquerque, New Mexico — Dr. Matt Campen studies the health effects of environmental pollutants. His lab at the University of New Mexico has, for the first time, found plastics in human brain tissue. He says his research estimates that the amount of plastic in the brain could be roughly equal to the size of a plastic spoon. "That is a lot," Campen explains to CBS News. "...The fact that it's getting worse over time is really the issue." Scientists believe these microscopic particles, called nanoplastics, come from all the plastic people use and throw away. When plastic breaks down over time, it winds up in the food supply, the water we drink, and even the air we breathe. A study last month in the Journal of the American Heart Association finds that people living near nanoplastic-polluted oceans are more likely to suffer from type 2 diabetes, heart disease, and stroke compared to those that lived near waters that have low levels of nanoplastics. Campen's lab has found more plastic in the brains of people with dementia than those without dementia. Now, research on these nanoplastics is moving out of the lab and into long-term clinical studies. "We have more evidence now for the effects of plastic on children's chronic disease then we do on food dyes," said Dr. Leonardo Trasande, a professor of pediatrics at New York University's Grossman School of Medicine. "And if we use the same evidence standard, we should be acting as fiercely on plastics in the food supply as we are on food dyes." Trasande is tracking plastics' impact on over 64,000 children, from pregnancy to adolescence, including on 8-year-old Jack Glaser. "The amount of information that they're collecting is remarkable," Glaser's mother, Tammy Fried-Glaser, said. "They did cognitive studies on Jack, you know, height and weight and sonograms, and beyond." So far, Trasande's research has linked plastics to health problems like hormonal issues with fertility, premature birth, cognitive abnormalities and cardiovascular disease. "Literally the particle is a problem — because it's a foreign body in a tissue," Trasande said. "It might thrash the lining of the coronary artery, contributing to are toxic drug delivery systems." While the details are still emerging, experts agree that less plastic is the way forward. While many believe 10,000 steps a day is optimal, new study suggests different DOJ's closed-door meetings with Ghislaine Maxwell fuels pardon speculation The impact of nanoplastics on long-term health Solve the daily Crossword

How nanoplastics may be impacting our long-term health
How nanoplastics may be impacting our long-term health

CBS News

time19 hours ago

  • CBS News

How nanoplastics may be impacting our long-term health

Albuquerque, New Mexico — Dr. Matt Campen studies the health effects of environmental pollutants. His lab at the University of New Mexico has, for the first time, found plastics in human brain tissue. He says his research estimates that the amount of plastic in the brain could be roughly equal to the size of a plastic spoon. "That is a lot," Campen explains to CBS News. "...The fact that it's getting worse over time is really the issue." Scientists believe these microscopic particles, called nanoplastics, come from all the plastic people use and throw away. When plastic breaks down over time, it winds up in the food supply, the water we drink, and even the air we breathe. A study last month in the Journal of the American Heart Association finds that people living near nanoplastic-polluted oceans are more likely to suffer from type 2 diabetes, heart disease, and stroke compared to those that lived near waters that have low levels of nanoplastics. Campen's lab has found more plastic in the brains of people with dementia than those without dementia. Now, research on these nanoplastics is moving out of the lab and into long-term clinical studies. "We have more evidence now for the effects of plastic on children's chronic disease then we do on food dyes," said Dr. Leonardo Trasande, a professor of pediatrics at New York University's Grossman School of Medicine. "And if we use the same evidence standard, we should be acting as fiercely on plastics in the food supply as we are on food dyes." Trasande is tracking plastics' impact on over 64,000 children, from pregnancy to adolescence, including on 8-year-old Jack Glaser. "The amount of information that they're collecting is remarkable," Glaser's mother, Tammy Fried-Glaser, said. "They did cognitive studies on Jack, you know, height and weight and sonograms, and beyond." So far, Trasande's research has linked plastics to health problems like hormonal issues with fertility, premature birth, cognitive abnormalities and cardiovascular disease. "Literally the particle is a problem — because it's a foreign body in a tissue," Trasande said. "It might thrash the lining of the coronary artery, contributing to are toxic drug delivery systems." While the details are still emerging, experts agree that less plastic is the way forward.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store